These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 30840279)
1. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p. Shi YF; Lu H; Wang HB Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279 [TBL] [Abstract][Full Text] [Related]
2. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer. Chen Z; Tang W; Ye W; Song L; Chen Z Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407 [TBL] [Abstract][Full Text] [Related]
3. Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p. Guo Q; Ni P; Dai Y; Hu J; Yao Y J Interferon Cytokine Res; 2021 Feb; 41(2):60-71. PubMed ID: 33621133 [TBL] [Abstract][Full Text] [Related]
4. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3. Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897 [TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186. Luo X; Song Y; Tang L; Sun DH; Ji DG Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320 [TBL] [Abstract][Full Text] [Related]
6. miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22. Li J; Lu M; Jin J; Lu X; Xu T; Jin S Cell Physiol Biochem; 2018; 50(1):136-149. PubMed ID: 30278449 [TBL] [Abstract][Full Text] [Related]
7. Lnc RNA ZFAS1 regulates the proliferation, apoptosis, inflammatory response and autophagy of fibroblast-like synoviocytes via miR-2682-5p/ADAMTS9 axis in rheumatoid arthritis. Yang S; Yin W; Ding Y; Liu F Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744323 [TBL] [Abstract][Full Text] [Related]
8. Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties. Liu X; Huang J; Xie Y; Zhou Y; Wang R; Lou J Med Sci Monit; 2019 Nov; 25():8905-8912. PubMed ID: 31760402 [TBL] [Abstract][Full Text] [Related]
9. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis. Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p. Yang Y; Xun N; Wu JG Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6971-6982. PubMed ID: 31486497 [TBL] [Abstract][Full Text] [Related]
11. Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro. Xiong H; Jin X; You C Med Sci Monit; 2018 Nov; 24():7883-7890. PubMed ID: 30391994 [TBL] [Abstract][Full Text] [Related]
12. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer. Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905 [TBL] [Abstract][Full Text] [Related]
13. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells. Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells. Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390 [TBL] [Abstract][Full Text] [Related]
15. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer. Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597 [TBL] [Abstract][Full Text] [Related]
16. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway. Wang A; Jin C; Li H; Qin Q; Li L Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751 [TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway. He SZ; Wang Q Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway. Lu PW; Li L; Wang F; Gu YT J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway. Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]